{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:38:42Z","timestamp":1762004322828},"reference-count":145,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1405,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1111\/j.1365-2796.2011.02456.x","type":"journal-article","created":{"date-parts":[[2011,9,19]],"date-time":"2011-09-19T17:53:56Z","timestamp":1316454836000},"page":"532-549","source":"Crossref","is-referenced-by-count":10,"title":["HIV testing and antiretroviral treatment strategies for prevention of HIV infection: impact on antiretroviral drug resistance"],"prefix":"10.1111","volume":"270","author":[{"given":"B. E.","family":"Nichols","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. A. B.","family":"Boucher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. A. M. C.","family":"van de Vijver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,10,27]]},"reference":[{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB1|cit1","volume-title":"Global Report: UNAIDS Report on the Global AIDS Epidemic 2010","author":"UNAIDS","year":"2010"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB2|cit2","first-page":"1","volume-title":"Key Facts by Region - 2008 Report on the Global AIDS Epidemic","author":"UNAIDS","year":"2008"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0140-6736(06)69162-9","article-title":"The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic","volume":"368","author":"Montaner","year":"2006","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1097\/01.aids.0000233579.79714.8d","article-title":"Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA","volume":"20","author":"Marks","year":"2006","journal-title":"AIDS"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1056\/NEJM200003303421303","article-title":"Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group","volume":"342","author":"Quinn","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/S0140-6736(10)60705-2","article-title":"Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis","volume":"375","author":"Donnell","year":"2010","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/01.aids.0000196566.40702.28","article-title":"Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda","volume":"20","author":"Bunnell","year":"2006","journal-title":"AIDS"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1097\/QAD.0b013e32832b7dca","article-title":"Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis","volume":"23","author":"Attia","year":"2009","journal-title":"AIDS"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/QAD.0b013e3283437c2b","article-title":"HIV-1 transmission among HIV-1 discordant couples before and after the introduction of antiretroviral therapy","volume":"25","author":"Reynolds","year":"2011","journal-title":"AIDS"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"c2205","DOI":"10.1136\/bmj.c2205","article-title":"Combined antiretroviral treatment and heterosexual transmission of HIV-1: cross sectional and prospective cohort study","volume":"340","author":"Del Romero","year":"2010","journal-title":"BMJ"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa1105243","article-title":"Prevention of HIV-1 infection with early antiretroviral therapy","volume":"365","author":"Cohen","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0140-6736(08)61697-9","article-title":"Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model","volume":"373","author":"Granich","year":"2009","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0140-6736(09)60640-1","article-title":"Universal voluntary HIV testing and immediate antiretroviral therapy","volume":"373","author":"Cohen","year":"2009","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0140-6736(09)60644-9","article-title":"Universal voluntary HIV testing and immediate antiretroviral therapy","volume":"373","author":"Jurgens","year":"2009","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0140-6736(09)60646-2","article-title":"Universal voluntary HIV testing and immediate antiretroviral therapy","volume":"373","author":"Jaffe","year":"2009","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0140-6736(09)60643-7","article-title":"Universal voluntary HIV testing and immediate antiretroviral therapy","volume":"373","author":"Epstein","year":"2009","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0140-6736(09)60645-0","article-title":"Universal voluntary HIV testing and immediate antiretroviral therapy","volume":"373","author":"Hsieh","year":"2009","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0140-6736(09)60641-3","article-title":"Universal voluntary HIV testing and immediate antiretroviral therapy","volume":"373","author":"Wilson","year":"2009","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0140-6736(09)60642-5","article-title":"Universal voluntary HIV testing and immediate antiretroviral therapy","volume":"373","author":"Ruark","year":"2009","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0140-6736(10)61442-0","article-title":"Costs of eliminating HIV in South Africa have been underestimated","volume":"376","author":"Wagner","year":"2010","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1086\/644505","article-title":"Transmission of drug-resistant HIV-1 is stabilizing in Europe","volume":"200","author":"Vercauteren","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB22|cit22","first-page":"17","volume-title":"HIV Sequence Compendium 2006\/2007","author":"van deVijver","year":"2007"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2217\/hiv.09.30","article-title":"Transmitted drug resistance in nonsubtype B HIV-1 infection","volume":"3","author":"Chan","year":"2009","journal-title":"HIV Therapy"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1473-3099(11)70032-9","article-title":"Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study","volume":"11","author":"Wittkop","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/infdis\/171.6.1411","article-title":"Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC)","volume":"171","author":"Schuurman","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1126\/science.287.5453.650","article-title":"A tale of two futures: HIV and antiretroviral therapy in San Francisco","volume":"287","author":"Blower","year":"2000","journal-title":"Science"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1473-3099(02)00346-8","article-title":"Could widespread use of combination antiretroviral therapy eradicate HIV epidemics?","volume":"2","author":"Velasco-Hernandez","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1086\/588673","article-title":"Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic","volume":"198","author":"Lima","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/QAD.0b013e32833433fe","article-title":"Examining the promise of HIV elimination by \u2018test and treat\u2019 in hyperendemic settings","volume":"24","author":"Dodd","year":"2010","journal-title":"AIDS"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1086\/655130","article-title":"Test and treat DC: forecasting the impact of a comprehensive HIV strategy in Washington DC","volume":"51","author":"Walensky","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1001\/archinternmed.2010.249","article-title":"Comparative effectiveness of HIV testing and treatment in highly endemic regions","volume":"170","author":"Bendavid","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nm0901-993","article-title":"Will the drugs still work? Transmission of resistant HIV","volume":"7","author":"Phillips","year":"2001","journal-title":"Nat Med"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1080\/00207160701750583","article-title":"Stochastic simulation of HIV population dynamics through complex network modeling","volume":"85","author":"Sloot","year":"2008","journal-title":"Int J Computer Math"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1001\/jama.292.2.224","article-title":"Highly active antiretroviral therapy and sexual risk behavior: a meta-analytic review","volume":"292","author":"Crepaz","year":"2004","journal-title":"JAMA"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1007\/s10461-009-9592-4","article-title":"Patterns of self-reported behaviour change associated with receiving voluntary counselling and testing in a longitudinal study from Manicaland, Zimbabwe","volume":"14","author":"Cremin","year":"2010","journal-title":"AIDS Behav"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1086\/590501","article-title":"HIV-1 transmission, by stage of infection","volume":"198","author":"Hollingsworth","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1086\/648729","article-title":"Improved virological outcomes in British Columbia concomitant with decreasing incidence of HIV type 1 drug resistance detection","volume":"50","author":"Gill","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0140-6736(10)60936-1","article-title":"Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study","volume":"376","author":"Montaner","year":"2010","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB40|cit40","volume-title":"Conference on Retroviruses and Opportunistic Infections","author":"Das MC","year":"2011"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"591","DOI":"10.7326\/0003-4819-146-8-200704170-00010","article-title":"Narrative review: antiretroviral therapy to prevent the sexual transmission of HIV-1","volume":"146","author":"Cohen","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S0140-6736(10)60528-4","article-title":"Kenya\u2019s HIV-testing drive runs into difficulties","volume":"375","author":"Alsop","year":"2010","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1001\/archinternmed.2010.248","article-title":"\u2018A bird in the hand...\u2019: a commentary on the test and treat approach for HIV","volume":"170","author":"Charlebois","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1097\/QAD.0b013e3281532c82","article-title":"Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection","volume":"21","author":"Pilcher","year":"2007","journal-title":"AIDS"},{"issue":"Suppl 1","key":"10.1111\/j.1365-2796.2011.02456.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1086\/650393","article-title":"Public health rationale for rapid nucleic acid or p24 antigen tests for HIV","volume":"201","author":"Pilcher","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1126\/science.1153843","article-title":"Public health. Reassessing HIV prevention","volume":"320","author":"Potts","year":"2008","journal-title":"Science"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(09)60998-3","article-title":"Circumcision in HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial","volume":"374","author":"Wawer","year":"2009","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0140-6736(07)60312-2","article-title":"Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial","volume":"369","author":"Bailey","year":"2007","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(07)60313-4","article-title":"Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial","volume":"369","author":"Gray","year":"2007","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB50|cit50","first-page":"37","article-title":"Male circumcision for prevention of heterosexual acquisition of HIV in men","volume":"1","author":"Siegfried","year":"2009","journal-title":"Cochrane Database Syst Rev (Online)"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/S0140-6736(00)02336-9","article-title":"Control of sexually transmitted diseases for HIV-1 prevention: understanding the implications of the Mwanza and Rakai trials","volume":"355","author":"Grosskurth","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0140-6736(95)91380-7","article-title":"Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial","volume":"346","author":"Grosskurth","year":"1995","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10461-006-9073-y","article-title":"Uganda\u2019s HIV prevention success: the role of sexual behavior change and the national response","volume":"10","author":"Green","year":"2006","journal-title":"AIDS Behav"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1126\/science.1093166","article-title":"Population-level HIV declines and behavioral risk avoidance in Uganda","volume":"304","author":"Stoneburner","year":"2004","journal-title":"Science"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/bmj.328.7444.891","article-title":"Partner reduction is crucial for balanced \u2018ABC\u2019 approach to HIV prevention","volume":"328","author":"Shelton","year":"2004","journal-title":"BMJ"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09540121.2011.579939","article-title":"Acceptability of male circumcision for prevention of HIV infection among men and women in Uganda","volume":"iFirst","author":"Albert","year":"2011","journal-title":"AIDS Care"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1080\/09540120412331299744","article-title":"The acceptability of male circumcision as an HIV intervention among a rural Zulu population, Kwazulu-Natal, South Africa","volume":"17","author":"Scott","year":"2005","journal-title":"AIDS Care"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-3156.2011.02744.x","article-title":"Prevalence and factors associated with knowledge of and willingness for male circumcision in rural Zimbabwe","volume":"16","author":"Mavhu","year":"2011","journal-title":"Trop Med Int Health"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S1473-3099(10)70167-5","article-title":"Population-based HIV-1 incidence in France, 2003-08: a modelling analysis","volume":"10","author":"Le Vu","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1468-1293.2009.00804.x","article-title":"Increasing HIV transmission through male homosexual and heterosexual contact in Australia: results from an extended back-projection approach","volume":"11","author":"Wand","year":"2010","journal-title":"HIV Med"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB61|cit61","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007496.pub2","article-title":"Male circumcision for prevention of homosexual acquisition of HIV in men","author":"Wiysonge","year":"2011","journal-title":"Cochrane Database Syst Rev (Online)"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0140-6736(98)06439-3","article-title":"Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group","volume":"353","author":"Wawer","year":"1999","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/sti.2008.032011","article-title":"Low effectiveness of syndromic treatment services for curable sexually transmitted infections in rural South Africa","volume":"84","author":"White","year":"2008","journal-title":"Sex Transm Infect"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1093\/cid\/cir244","article-title":"Men who have sex with men, risk behavior, and HIV infection: integrative analysis of clinical, epidemiological, and laboratory databases","volume":"52","author":"Levy","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.2010.1004","article-title":"Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel","volume":"304","author":"Thompson","year":"2010","journal-title":"JAMA"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1056\/NEJMoa0807252","article-title":"Effect of early versus deferred antiretroviral therapy for HIV on survival","volume":"360","author":"Kitahata","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/QAD.0b013e3283324283","article-title":"The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals","volume":"24","author":"Ray","year":"2010","journal-title":"AIDS (London, England)"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S0140-6736(09)60612-7","article-title":"Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies","volume":"373","author":"Sterne","year":"2009","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"509","DOI":"10.7326\/0003-4819-154-8-201104190-00001","article-title":"When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study","volume":"154","author":"Collaboration TH-C","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1086\/651688","article-title":"Incidence of malignancies in HIV-infected patients and prognostic role of current CD4 cell count: evidence from a large Italian cohort study","volume":"50","author":"Prosperi","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0140-6736(10)60269-3","article-title":"Early initiation of treatment for HIV infection","volume":"375","author":"Phillips","year":"2010","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/QAD.0b013e328333fa0f","article-title":"Late diagnosis in the HAART era: proposed common definitions and associations with mortality","volume":"24","author":"CHIC","year":"2010","journal-title":"AIDS"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1086\/652650","article-title":"Late presentation for human immunodeficiency virus care in the United States and Canada","volume":"50","author":"Althoff","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB74|cit74","article-title":"At front lines, AIDS war Is falling apart","author":"McNeil","journal-title":"New York Times"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB75|cit75","first-page":"1","volume-title":"Rapid Advice: Antiretroviral Therapy for HIV Infection in Adults and Adolescents","author":"WHO","year":"2009"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"e298","DOI":"10.1371\/journal.pmed.0040298","article-title":"Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review","volume":"4","author":"Rosen","year":"2007","journal-title":"PLoS Med"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1097\/QAI.0b013e3182075ae2","article-title":"Retention in HIV care for individuals not yet eligible for antiretroviral therapy: Rural KwaZulu-Natal, South Africa","volume":"56","author":"Lessells","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S1473-3099(09)70136-7","article-title":"Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis","volume":"9","author":"Gupta","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1086\/648444","article-title":"Viremia, resuppression, and time to resistance in Human Immunodeficiency Virus (HIV) subtype C DURING first-line antiretroviral therapy in South Africa","volume":"49","author":"Hoffmann","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1086\/648590","article-title":"Viral rebound and emergence of drug resistance in the absence of viral load testing: a randomized comparison between zidovudine-lamivudine plus Nevirapine and zidovudine-lamivudine plus Abacavir","volume":"201","author":"Ndembi","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0140-6736(10)60676-9","article-title":"Antiretroviral therapy and management of HIV infection","volume":"376","author":"Volberding","year":"2010","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB82|cit82","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0140-6736(09)61313-1","article-title":"Antiretroviral roll-out: the problem of second-line therapy","volume":"374","author":"Boyd","year":"2009","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB83|cit83","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/QAD.0b013e3283360976","article-title":"The high cost of second-line antiretroviral therapy for HIV\/AIDS in South Africa","volume":"24","author":"Long","year":"2010","journal-title":"AIDS"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB84|cit84","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/QAD.0b013e3282f5e062","article-title":"Transmission of drug-resistant HIV-1 in Europe remains limited to single classes","volume":"22","author":"Spread-programme","year":"2008","journal-title":"AIDS"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1097\/00002030-200111230-00010","article-title":"Acute HIV infection: impact on the spread of HIV and transmission of drug resistance","volume":"15","author":"Yerly","year":"2001","journal-title":"AIDS"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1086\/512088","article-title":"High rates of forward transmission events after acute\/early HIV-1 infection","volume":"195","author":"Brenner","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB87|cit87","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1086\/432916","article-title":"Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management","volume":"192","author":"Wensing","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB88|cit88","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1086\/651684","article-title":"Long-term probability of detecting drug-resistant HIV in treatment-naive patients initiating combination antiretroviral therapy","volume":"50","author":"UK-CHIC","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB89|cit89","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0140-6736(06)68580-2","article-title":"Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment","volume":"367","author":"Ferradini","year":"2006","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB90|cit90","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1097\/QAD.0b013e32833a097b","article-title":"Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa","volume":"24","author":"El-Khatib","year":"2010","journal-title":"AIDS"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB91|cit91","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1097\/QAI.0b013e3182208003","article-title":"Association between medication possession ratio, virologic failure and drug resistance in HIV-1 infected adults on antiretroviral therapy in Cote d\u2019Ivoire","volume":"57(Suppl 1)","author":"Messou","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB92|cit92","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.trstmh.2008.07.014","article-title":"Viraemia and HIV-1 drug resistance mutations among patients receiving antiretroviral treatment in Mozambique","volume":"103","author":"Maldonado","year":"2009","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB93|cit93","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/QAI.0b013e31819ff102","article-title":"Response to zidovudine\/didanosine-containing combination antiretroviral therapy among HIV-1 subtype C-infected adults in Botswana: two-year outcomes from a randomized clinical trial","volume":"51","author":"Bussmann","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB94|cit94","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1471-2334-9-108","article-title":"Virological efficacy and emergence of drug resistance in adults on antiretroviral treatment in rural Tanzania","volume":"9","author":"Johannessen","year":"2009","journal-title":"BMC Infect Dis"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB95|cit95","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(04)16586-0","article-title":"Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial","volume":"364","author":"Laurent","year":"2004","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB96|cit96","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1086\/599611","article-title":"High frequency of antiretroviral drug resistance among HIV-infected adults receiving first-line highly active antiretroviral therapy in N\u2019Djamena, Chad","volume":"49","author":"Koyalta","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB97|cit97","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1097\/QAD.0b013e3282f08cdc","article-title":"Risk factors for lactic acidosis and severe hyperlactataemia in HIV-1-infected adults exposed to antiretroviral therapy","volume":"21","author":"Lactic Acidosis International Study Group","year":"2007","journal-title":"AIDS"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB98|cit98","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/01.qai.0000209899.05126.e4","article-title":"The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes","volume":"41","author":"van de Vijver","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"Suppl 2","key":"10.1111\/j.1365-2796.2011.02456.x-BIB99|cit99","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1097\/00126334-200310012-00002","article-title":"Preventing and managing resistance in the clinical setting","volume":"34","author":"Kuritzkes","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB100|cit100","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/S0140-6736(03)15022-2","article-title":"Treatment of antiretroviral-drug-resistant HIV-1 infection","volume":"362","author":"Deeks","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB101|cit101","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/infdis\/165.1.105","article-title":"Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects","volume":"165","author":"Boucher","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB102|cit102","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1097\/QAI.0b013e3182097505","article-title":"Implementing a tenofovir-based first-line regimen in rural lesotho: clinical outcomes and toxicities after two years","volume":"56","author":"Bygrave","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB103|cit103","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/QAI.0b013e3181b05f7c","article-title":"Development of HIV-1 drug resistance through 144\u2003weeks in antiretroviral-naive subjects on emtricitabine, tenofovir disoproxil fumarate, and efavirenz compared with lamivudine\/zidovudine and efavirenz in study GS-01-934","volume":"52","author":"Margot","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB104|cit104","first-page":"140","article-title":"Worldwide transmission of drug-resistant HIV","volume":"5","author":"Wensing","year":"2003","journal-title":"AIDS Rev"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB105|cit105","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/jac\/dkm082","article-title":"Prevalence and determinants of transmitted antiretroviral drug resistance in HIV-1 infection","volume":"59","author":"Booth","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB106|cit106","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1177\/135965350801300502","article-title":"The status of HIV-1 resistance to antiretroviral drugs in sub-Saharan Africa","volume":"13","author":"Hamers","year":"2008","journal-title":"Antivir Ther"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB107|cit107","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/aid.2010.0030","article-title":"Transmitted HIV type 1 drug resistance among individuals with recent HIV infection in East and Southern Africa","volume":"27","author":"Price","year":"2011","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB108|cit108","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/QAI.0b013e3181e544e0","article-title":"HIV-1 drug resistance mutations are present in six percent of persons initiating antiretroviral therapy in Lusaka, Zambia","volume":"55","author":"Hamers","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB109|cit109","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1089\/aid.2009.0299","article-title":"Prevalence of transmitted HIV Drug Resistance (HIVDR) in Botswana: lessons learned from the HIVDR-threshold survey conducted among women presenting for routine antenatal care as part of the 2007 National Sentinel Survey","volume":"27","author":"Bussmann","year":"2011","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB110|cit110","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1089\/aid.2010.0113","article-title":"Prevalence of genotypic resistance to antiretroviral drugs in treatment-naive youths Infected with diverse HIV Type 1 subtypes and recombinant forms in Dar es Salaam, Tanzania","volume":"27","author":"Mosha","year":"2010","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB111|cit111","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1002\/jmv.21600","article-title":"Analysis of the diversity of the HIV-1 pol gene and drug resistance associated changes among drug-naive patients in Burkina Faso","volume":"81","author":"Tebit","year":"2009","journal-title":"J Med Virol"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB112|cit112","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/QAI.0b013e3181a24906","article-title":"HIV-1 genetic diversity and transmitted drug resistance in health care settings in Maputo, Mozambique","volume":"51","author":"Bartolo","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB113|cit113","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/135965350901400313","article-title":"Evaluation of transmitted HIV drug resistance among recently-infected antenatal clinic attendees in four Central African countries","volume":"14","author":"Aghokeng","year":"2009","journal-title":"Antivir Ther"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB114|cit114","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/QAD.0b013e328327957a","article-title":"Antiretroviral drug susceptibility among drug-naive adults with recent HIV infection in Rakai, Uganda","volume":"23","author":"Eshleman","year":"2009","journal-title":"AIDS"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB115|cit115","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1089\/aid.2009.0142","article-title":"Low prevalence of HIV type 1 drug resistance mutations in untreated, recently infected patients from Burkina Faso, Cote d\u2019Ivoire, Senegal, Thailand, and Vietnam: the ANRS 12134 study","volume":"25","author":"Ayouba","year":"2009","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB116|cit116","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/QAD.0b013e3283388742","article-title":"Prevalence of transmitted drug resistance associated mutations and HIV-1 subtypes in new HIV-1 diagnoses, U.S.-2006","volume":"24","author":"Wheeler","year":"2010","journal-title":"AIDS"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB117|cit117","doi-asserted-by":"crossref","first-page":"e1000233","DOI":"10.1371\/journal.pmed.1000233","article-title":"Effectiveness of non-nucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in women previously exposed to a single intrapartum dose of nevirapine: a multi-country, Prospective Cohort Study","volume":"7","author":"Stringer","year":"2010","journal-title":"PLoS Med"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB118|cit118","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1056\/NEJMoa0906626","article-title":"Antiretroviral therapies in women after single-dose nevirapine exposure","volume":"363","author":"Lockman","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB119|cit119","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0140-6736(03)14341-3","article-title":"Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial","volume":"362","author":"Jackson","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB120|cit120","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1086\/650746","article-title":"Another milestone in minimizing risks to mothers exposed to single-dose nevirapine for prevention of vertical transmission of HIV-1 to infants: what next?","volume":"50","author":"Cotton","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB121|cit121","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/jama.288.2.181","article-title":"Time trends in primary HIV-1 drug resistance among recently infected persons","volume":"288","author":"Grant","year":"2002","journal-title":"JAMA"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB122|cit122","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1136\/bmj.38665.534595.55","article-title":"Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational study","volume":"331","author":"Cane","year":"2005","journal-title":"BMJ"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB123|cit123","doi-asserted-by":"crossref","first-page":"e11505","DOI":"10.1371\/journal.pone.0011505","article-title":"Comparison of HIV-1 genotypic resistance test interpretation systems in predicting virological outcomes over time","volume":"5","author":"Frentz","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB124|cit124","first-page":"3","article-title":"HIV-1 drug-resistance patterns among patients on failing treatment in a large number of European countries","volume":"19","author":"van deVijver","year":"2010","journal-title":"Acta Dermatovenerol Alp Panonica Adriat"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB125|cit125","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/QAI.0b013e318074eb73","article-title":"Prevalence of HIV-1 drug resistance in treated patients: a French Nationwide Study","volume":"46","author":"Costagliola","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB126|cit126","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00001432-200102000-00005","article-title":"Implications of antiretroviral resistance on viral fitness","volume":"14","author":"Nijhuis","year":"2001","journal-title":"Curr Opin Infect Dis"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB127|cit127","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1097\/00126334-200412150-00017","article-title":"Diminished representation of HIV-1 variants containing select drug resistance-conferring mutations in primary HIV-1 infection","volume":"37","author":"Turner","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB128|cit128","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1128\/JCM.43.3.1395-1400.2005","article-title":"Diminished replicative fitness of primary human immunodeficiency virus type 1 isolates harboring the K65R mutation","volume":"43","author":"Weber","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB129|cit129","doi-asserted-by":"crossref","first-page":"e4724","DOI":"10.1371\/journal.pone.0004724","article-title":"Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update","volume":"4","author":"Bennett","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB130|cit130","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1097\/00002030-200312050-00002","article-title":"Genetic diversity of HIV in Africa: impact on diagnosis, treatment, vaccine development and trials","volume":"17","author":"Peeters","year":"2003","journal-title":"AIDS"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB131|cit131","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1086\/379215","article-title":"Emergence of minor populations of human immunodeficiency virus type 1 carrying the M184V and L90M mutations in subjects undergoing structured treatment interruptions","volume":"188","author":"Metzner","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB132|cit132","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1086\/595703","article-title":"Minority quasispecies of drug-resistant HIV-1 that lead to early therapy failure in treatment-naive and -adherent patients","volume":"48","author":"Metzner","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB133|cit133","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1086\/651136","article-title":"Efficient suppression of minority drug-resistant HIV type 1 (HIV-1) variants present at primary HIV-1 infection by ritonavir-boosted protease inhibitor-containing antiretroviral therapy","volume":"201","author":"Metzner","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB134|cit134","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1097\/01.aids.0000189878.97480.ed","article-title":"Detection of minor populations of drug-resistant HIV-1 in acute seroconverters","volume":"19","author":"Metzner","year":"2005","journal-title":"AIDS"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB135|cit135","first-page":"662","article-title":"Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure","volume":"201","author":"Paredes","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB136|cit136","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/QAD.0b013e328333ddee","article-title":"Transmission networks of HIV-1 among men having sex with men in the Netherlands","volume":"24","author":"Bezemer","year":"2010","journal-title":"AIDS"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB137|cit137","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1097\/QAD.0b013e3283121c90","article-title":"Transmission networks of drug resistance acquired in primary\/early stage HIV infection","volume":"22","author":"Brenner","year":"2008","journal-title":"AIDS"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB138|cit138","volume-title":"Richtlijn Antiretrovirale Behandeling","author":"Nederlandse vereniging van Ab","year":"2005"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB139|cit139","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S1473-3099(10)70189-4","article-title":"HIV status in discordant couples in sub-Saharan Africa: a systematic review and meta-analysis","volume":"10","author":"Eyawo","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB140|cit140","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/QAI.0b013e3181ac12bf","article-title":"Number of named partners and number of partners newly diagnosed with HIV infection identified by persons with acute versus established HIV infection","volume":"52","author":"Moore","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB141|cit141","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1193748","article-title":"Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women","volume":"329","author":"Abdool Karim","year":"2010","journal-title":"Science"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB142|cit142","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men","volume":"363","author":"Grant","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB143|cit143","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/QCO.0b013e32833ff1e6","article-title":"The risk of HIV drug resistance following implementation of pre-exposure prophylaxis","volume":"23","author":"van de Vijver","year":"2010","journal-title":"Curr Opin Infect Dis"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB144|cit144","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1086\/597095","article-title":"HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness","volume":"48","author":"Paltiel","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1365-2796.2011.02456.x-BIB145|cit145","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1086\/597804","article-title":"Circulating HIV type 1 drug resistance will have limited impact on the effectiveness of preexposure prophylaxis among young women in Zimbabwe","volume":"199","author":"van de Vijver","year":"2009","journal-title":"J Infect Dis"}],"container-title":["Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2796.2011.02456.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2796.2011.02456.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T00:57:45Z","timestamp":1712883465000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2796.2011.02456.x"}},"subtitle":["Symposium: Prevention of HIV based on test and treat"],"short-title":[],"issued":{"date-parts":[[2011,10,27]]},"references-count":145,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2796.2011.02456.x","relation":{},"ISSN":["0954-6820"],"issn-type":[{"value":"0954-6820","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10,27]]}}}